Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: allen menglin chen who wrote (450)	6/23/2000 8:10:00 PM
From: gao seng	Read Replies (1) \| Respond to of 746

ADVISORY/Celera Genomics and National Institutes of Health and Department of Energy News Briefing On Updates On the Human Genome Business Wire - June 23, 2000 19:15 Jump to first matched term --(BW HealthWire)-- WHO: J. Craig Venter, Ph.D., Celera Genomics, President and Chief Scientific Officer WHAT: Celera Genomics to hold news briefing to announce the first assembly of the human genome. The NIH, DOE, and international partners will announce a working draft of the human genome. WHEN: MONDAY, JUNE 26, 2000 12:30 PM EDT WHERE: Join us at the Capitol Hilton 1001 16th Street, NW Washington, DC 20036 Company Background Celera's mission is to become the definitive source of genomic and related medical and biological information. Users of Celera's information, available on a subscription basis to academic and commercial institutions, will have access to tools for viewing, browsing and analyzing data in an integrated way that will assist scientists in accelerating their understanding of the human genetic code. PE Corporation comprises two operating groups. The PE Biosystems Group (NYSE:PEB), with sales of $1.2 billion during fiscal 1999, develops and markets instrument-based systems, reagents, software and contract services to the life science industry and research community. The Celera Genomics Group (NYSE:CRA), headquartered in Rockville, MD, intends to become the definitive source of genomic and related medical information. PE Biosystems is headquartered in Foster City, CA, and comprises four divisions: Applied Biosystems, PE Informatics, PerSeptive Biosystems, and Tropix. Information about the Company, including reports and other information filed by the Company with the Securities and Exchange Commission, is available on the worldwide web at www.pecorporation.com or by phoning 800.762.6923. CONTACT: Celera Genomics Heather Kowalski, 240/453-3343 marketwatch.newsalert.com